TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Oct 20, 2020 11:00 JST
Source:
Olympus
Olympus to Support Endoscopic AI Diagnosis Education for Doctors in India and to Launch AI Diagnostic Support Application
Participating in Ministry of Internal Affairs and Communications project: "Survey Study for International Expansion of AI Diagnosis Support System Using Ultra-High Magnifying Endoscopes in India"
TOKYO, Oct 20, 2020 - (ACN Newswire) - Olympus Corporation took part in a ground-breaking project as a business promoter, in cooperation with the Ministry of Internal Affairs and Communications (MIC), entitled, "Survey Study for International Expansion of AI Diagnosis Support System Using Ultra-High Magnifying Endoscopes in India." The project aims to develop advanced endoscopy diagnostics in India, where there are relatively few endoscopists.
In collaboration with CYBERNET SYSTEMS CO,. LTD., Olympus has established an AI diagnostic support system at a major medical institution, the Asian Institute of Gastroenterology (AIG) based in Hyderabad, India. Specialist lecturers and physicians from Showa University Northern Yokohama Hospital provided expert guidance to AIG doctors. In addition to training AIG doctors in techniques for detecting diseases and differential diagnosis by colonoscope, they also trained the doctors on how to instruct the next generation of endoscopists.
The project started on October 12. At the kick-off meeting, Satoshi Hemmi, Deputy Director-General of the Information and Communications Bureau, the Ministry of Internal Affairs and Communications commented, "We hope to contribute to the spread of AI endoscopy systems and the development of medical care in India through training future leaders in AI endoscopy systems in India. We also hope that the cooperation between India and Japan in the field of healthcare ICT will continue to develop."
In addition to the ultra-magnifying scope Endocyto(*1) released last year, Olympus will release endoscopic diagnostic support software equipped with AI in India from December. The endoscopic diagnostic support software EndoBRAIN(*2) and EndoBRAIN-EYE(*3) will be utilized for physician training in India. Olympus intends to assist in the development of physicians and promote the use of endoscopic diagnostics.
(*1) An endoscope that enables observation at the cellular level in real time with up to 520 times optical magnification.
(*2) AI real-time in-vivo analysis of colon lesions taken with ultra-high magnifying endoscopes, numerically indicating the possibility of neoplastic and non-neoplastic polyps to assist physicians in the differentiation and detection of polyps through figures.
(*3) AI endoscopic diagnostic imaging support software that assists physicians in diagnosing lesions by alerting if a polyp or other lesion is detected using regular colonoscope images.
Background of Olympus' Participation
In India, the rate of cancer morbidity is expected to increase as the economy grows. On the other hand, there is a severe shortage of doctors who can conduct precision diagnostics with endoscopes, which are essential for early detection and treatment of cancer. Olympus participated in this project to support trained AIG specialists to train doctors in India and neighboring countries and to contribute to the popularization and development of endoscope diagnostics using the latest AI technology.
Ministry of Internal Affairs and Communications Project
- Purpose:
The MIC aims to realize the sustainable development goal and SDG pledges to ensure "no one will be left behind." To this end, the MIC aims to realize a model that contributes to SDG through digitization and to disseminate and promote an SDG + ICT model domestically and overseas between both public and private sectors. This project aims to contribute to the introduction and dissemination of Japan's endoscopic AI diagnostic support system to India and neighboring countries in response to the social issue of increasing cancer prevalence in India.
- Projects:
1) Survey on the Current Status of Policies in the Medical Health Sector in India and the Current Status of the Introduction of Medical ICT in India:
Collecting information from major medical institutions and external research institutions and investigating the spread of medical systems, including endoscopic systems.
2) Verification through proof-of-concept tests in India:
Physicians from the Showa University Northern Yokohama Hospital will train AIG physicians, from the detection of disease utilizing a colonoscope to discriminatory diagnosis, and train them as lecturers to train instructors. MIC provided equipment and training courses.
For questions or additional information, please contact:
Yuka Horimoto
+81-90-2490-1071
yuka.horimoto@olympus.com
Source: Olympus
Sectors: BioTech, Healthcare & Pharm, ASEAN, Artificial Intel [AI], MedTech
Copyright ©2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
Olympus Announces Leadership Succession Plan
October 21 2022 14:00 JST
Olympus EU-ME3 Ultrasound Processor, Delivers Higher Resolution Images for Endoscopic Ultrasound
October 10 2022 14:00 JST
Olympus to Use 100% Renewable Electricity at R&D and Manufacturing Sites in Japan
June 14 2022 12:00 JST
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
November 12 2021 07:30 JST
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices
September 21 2021 12:00 JST
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices
September 21 2021 12:00 JST
Olympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Business
April 08 2021 10:00 JST
Olympus Supports Dissemination of Endoscopic Procedures for Colorectal Cancer in Russia
February 04 2021 10:00 JST
Olympus launches comprehensive global educational platform for healthcare professionals
February 01 2021 08:00 JST
Olympus announces acquisition of FH ORTHO, an international orthopedics company in France
November 02 2020 14:00 JST
More Press release >>
Latest Press Release
Sharp Acquires Vietnamese Corporation Engaged in Solar EPC And O&M Business as A Wholly Owned Subsidiary
Jul 27, 2026 22:02 JST
Collaboration Agreement announced by Sovereign Effects Partners to support GCAP
Jul 27, 2026 21:49 JST
Chunghwa Telecom, Fujitsu and 1Finity to accelerate All-Photonics Network deployment and advance quantum technologies in Taiwan through strategic partnership
Jul 27, 2026 21:08 JST
JCB and Fiuu Collaborate to Expand JCB Acceptance Across Southeast Asia
Jul 23, 2026 12:00 JST
Marketing Authorization Application for In-house Developed Insomnia Drug Lemborexant Accepted for Evaluation by European Medicines Agency (EMA)
Jul 18, 2026 00:24 JST
Hitachi and NVIDIA collaborate to advance HMAX and enable end-to-end autonomous operations through the integrated control of physical AI
Jul 17, 2026 23:35 JST
Toyota's First "BE creation" Spin-Off Begins Operations in Japan
Jul 17, 2026 23:00 JST
MHI Advances AI Infrastructure Commercialization with U.S. Deployment of 10MW-Class Chiller and MCP Development
Jul 17, 2026 22:47 JST
Noetra Launches Full-Scale R&D for Japan-Developed Multimodal Foundation Model
Jul 17, 2026 22:16 JST
Mitsubishi Motors Launches the Xforce HEV in Indonesia
Jul 17, 2026 21:47 JST
Fujitsu to explore physical AI development and implementation across industries with FANUC, Yaskawa Electric, and Kawasaki Heavy Industries integrating NVIDIA technology
Jul 17, 2026 21:05 JST
JCB Celebrates 30 Years of Trust, Honoring 70 Years of Japan-Philippines Friendship
Jul 17, 2026 10:00 JST
TANAKA Commences Operation of "TANAKA H2 Nexus", One of Japan's Largest 500 kW Pure Hydrogen Fuel Cell Power Generation Facilities
Jul 16, 2026 22:00 JST
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Jul 16, 2026 00:18 JST
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
Jul 15, 2026 23:51 JST
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference(R) (AAIC(R)) 2026
Jul 15, 2026 23:21 JST
NEC develops world's first proprietary-AI technology to rapidly generate highly detailed 3D models solely from general-purpose camera footage while automatically removing unnecessary subjects
Jul 15, 2026 22:53 JST
Hitachi Rail achieves EcoVadis platinum medal, ranking among the top 1% of companies worldwide for sustainability performance
Jul 15, 2026 22:35 JST
Anime Tokyo Station Reaches 300,000 Visitors!
Jul 15, 2026 11:00 JST
Fujitsu launches AI-driven modernization service to accelerate legacy system transformation
Jul 14, 2026 19:12 JST
More Latest Release >>